Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000899243-22-031498

Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
THOMAS FRANK E Director 2022-09-15 Grant or award +15,000 15,000 D
Loading xslF345X03/doc4.xml…